芒果视频下载

全球開放式、一體化生物制藥能力和技術賦能平臺，專注于為全球生物制藥公司提供端到端研發服務的上市公司

藥(yao)(yao)(yao)(yao)明生(sheng)物(wu)(wu)(wu)（股(gu)票代(dai)碼(ma)：2269.HK）作(zuo)為(wei)一(yi)家香(xiang)港上市公(gong)司，是全(quan)(quan)球(qiu)開放式、一(yi)體化(hua)生(sheng)物(wu)(wu)(wu)制(zhi)藥(yao)(yao)(yao)(yao)能力和技(ji)(ji)術賦能平臺(tai)。公(gong)司為(wei)全(quan)(quan)球(qiu)生(sheng)物(wu)(wu)(wu)制(zhi)藥(yao)(yao)(yao)(yao)公(gong)司和生(sheng)物(wu)(wu)(wu)技(ji)(ji)術公(gong)司提供(gong)端到端研發服務，幫助任(ren)(ren)何人、任(ren)(ren)何公(gong)司發現、開發及生(sheng)產生(sheng)物(wu)(wu)(wu)藥(yao)(yao)(yao)(yao)，實現從概念到商(shang)業化(hua)生(sheng)產的(de)(de)全(quan)(quan)過(guo)程(cheng)，加速全(quan)(quan)球(qiu)生(sheng)物(wu)(wu)(wu)藥(yao)(yao)(yao)(yao)研發進程(cheng)，降低(di)研發成本(ben)，造(zao)福病患。截至2018年12月31日，在藥(yao)(yao)(yao)(yao)明生(sheng)物(wu)(wu)(wu)平臺(tai)上研發的(de)(de)綜合項目達(da)205個，包括97個處(chu)于臨床(chuang)(chuang)前研究階段，94個在臨床(chuang)(chuang)早期（I期，II期）階段，13個在后期臨床(chuang)(chuang)（III期）以及1個在商(shang)業化(hua)生(sheng)產階段。預計到2022年，公(gong)司在中國、愛(ai)爾蘭、新加坡、美國規劃的(de)(de)生(sheng)物(wu)(wu)(wu)制(zhi)藥(yao)(yao)(yao)(yao)生(sheng)產基地合計產能約22萬升，這將(jiang)有力促使公(gong)司通過(guo)健全(quan)(quan)強大的(de)(de)全(quan)(quan)球(qiu)供(gong)應鏈網絡為(wei)客(ke)戶(hu)提供(gong)符(fu)合全(quan)(quan)球(qiu)質量標準的(de)(de)生(sheng)物(wu)(wu)(wu)藥(yao)(yao)(yao)(yao)。

藥明生(sheng)(sheng)物(wu)(wu)(wu)是(shi)全(quan)(quan)球(qiu)開(kai)放式、一體(ti)化生(sheng)(sheng)物(wu)(wu)(wu)制(zhi)藥能(neng)力和技(ji)術(shu)賦(fu)能(neng)平(ping)臺。公(gong)(gong)司(si)為(wei)全(quan)(quan)球(qiu)生(sheng)(sheng)物(wu)(wu)(wu)制(zhi)藥公(gong)(gong)司(si)和生(sheng)(sheng)物(wu)(wu)(wu)技(ji)術(shu)公(gong)(gong)司(si)提供端到(dao)端研(yan)(yan)發(fa)(fa)服(fu)務(wu)，幫助(zhu)任何人(ren)、任何公(gong)(gong)司(si)發(fa)(fa)現、開(kai)發(fa)(fa)及生(sheng)(sheng)產生(sheng)(sheng)物(wu)(wu)(wu)藥，實現從概(gai)念(nian)到(dao)商業化生(sheng)(sheng)產的全(quan)(quan)過程。公(gong)(gong)司(si)通(tong)過高質量、一體(ti)化服(fu)務(wu)賦(fu)能(neng)全(quan)(quan)球(qiu)客戶，提高研(yan)(yan)發(fa)(fa)效率，降低研(yan)(yan)發(fa)(fa)成(cheng)本，進一步加速生(sheng)(sheng)物(wu)(wu)(wu)藥研(yan)(yan)發(fa)(fa)進程。